These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 25976937)
1. Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein. Folch J; Ettcheto M; Petrov D; Abad S; Pedrós I; Marin M; Olloquequi J; Camins A Neurologia (Engl Ed); 2018; 33(1):47-58. PubMed ID: 25976937 [TBL] [Abstract][Full Text] [Related]
2. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
3. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease. Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875 [TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767 [TBL] [Abstract][Full Text] [Related]
6. Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies. Vijayan D; Chandra R Curr Drug Targets; 2020; 21(2):148-166. PubMed ID: 31385768 [TBL] [Abstract][Full Text] [Related]
7. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891 [TBL] [Abstract][Full Text] [Related]
8. The past, present, and future of disease-modifying therapies for Alzheimer's disease. Suzuki K; Iwata A; Iwatsubo T Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305 [TBL] [Abstract][Full Text] [Related]
9. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
10. Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches. Mikulca JA; Nguyen V; Gajdosik DA; Teklu SG; Giunta EA; Lessa EA; Tran CH; Terak EC; Raffa RB J Clin Pharm Ther; 2014 Feb; 39(1):25-37. PubMed ID: 24313554 [TBL] [Abstract][Full Text] [Related]
11. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review. Ahmad SS; Khan S; Kamal MA; Wasi U CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840 [TBL] [Abstract][Full Text] [Related]
12. γ-Secretase and its modulators: Twenty years and beyond. Xia W Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650 [TBL] [Abstract][Full Text] [Related]
13. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893 [TBL] [Abstract][Full Text] [Related]
14. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation. Son SM; Shin HJ; Byun J; Kook SY; Moon M; Chang YJ; Mook-Jung I J Alzheimers Dis; 2016; 51(4):1197-208. PubMed ID: 26967226 [TBL] [Abstract][Full Text] [Related]
15. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. Cai Z; Wang C; He W; Chen Y Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease drug development based on Computer-Aided Drug Design. Zeng H; Wu X Eur J Med Chem; 2016 Oct; 121():851-863. PubMed ID: 26415837 [TBL] [Abstract][Full Text] [Related]
17. Phenylpropanoids from cinnamon bark reduced β-amyloid production by the inhibition of β-secretase in Chinese hamster ovarian cells stably expressing amyloid precursor protein. Kang YJ; Seo DG; Park SY Nutr Res; 2016 Nov; 36(11):1277-1284. PubMed ID: 27865616 [TBL] [Abstract][Full Text] [Related]
18. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways. Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755 [TBL] [Abstract][Full Text] [Related]
19. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production. Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459 [TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological basis for therapeutic inhibition of beta- and gamma-secretases in mouse models of Alzheimer's memory deficits. Ohno M Rev Neurosci; 2006; 17(4):429-54. PubMed ID: 17139843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]